Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UX Upgrade For Genomics Reports, AI Diagnostic Partnership Announced

Updates from the HLTH 2022 Conference

Executive Summary

Foundation Medicine, NVIDIA and Nuance were among the companies that announced key initiatives during the HLTH conference in Las Vegas this week.

You may also be interested in...



Collaboration Key To The Widespread Adoption Of AI For Health Care

Artificial intelligence (AI) vendors are partnering with health care providers to identify practical challenges and consider AI technology as a potential solution. This type of collaboration is crucial to successful AI adoption because the technology is designed to tackle real-world health care problems. A myriad of examples was displayed at the recent RSNA 2020 meeting.

Partnerships Are Key To Foundation Medicine's Success

Since receiving approval for the first broad-panel diagnostic test as a combination product to detect cancer, Foundation Medicine has ramped up its partnerships with pharmaceutical companies and other stakeholders. The company expects to receive a similar approval for a broad-panel liquid biopsy genomic test in the first half of 2020.

Sterigenics Wins Second Lawsuit In Ongoing Ethylene Oxide Court Battles

In the second trial over Sterigenics’ ethylene oxide plant emissions, the Cook County, IL jury found Stergiencs not liable for cancer in a woman who lived near the plant.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT146055

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel